Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: Assessment by optical coherence tomography study

Atherosclerosis

Volumn 202, Issue 2, 2009, Pages 491-497

  Takarada, Shigeho ^a   Imanishi, Toshio ^a   Kubo, Takashi ^a   Tanimoto, Takashi ^a   Kitabata, Hironori ^a   Nakamura, Nobuo ^a   Tanaka, Atsushi ^a   Mizukoshi, Masato ^a   Akasaka, Takashi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Optical coherence tomography; Plaque; Statin

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC ACID DERIVATIVE; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORONARY FIBROUS CAP; DIET THERAPY; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYPERLIPIDEMIA; MALE; OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THICKNESS; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; UNSPECIFIED SIDE EFFECT;

ACUTE CORONARY SYNDROME; AGED; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TRIGLYCERIDES;

EID: 58549095873     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.05.014     Document Type: Article

References (20)

1. Kaiser C., Brunner-La Rocca H.P., Buser P.T., et al. BASKET investigators. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare metal stent in a real-world setting: randomized Basel Stent Kosten Effektivitats Trial (BASKET). Lancet 366 (2005) 921-929
2. Arntz H.R., Agrawal R., Wunderlich W., et al. Beneficial effects of pravastatin (±colestyramine/niacin) initiated immediately after a coronary event (the randomized lipid-coronary artery disease [L-CAD] study). Am J Cardiol 86 (2000) 1293-1298
3. Schwartz G.G., Olsson A.G., Ezekowitz M.D., et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: MIRACLE study: a randomized controlled trial. JAMA 285 (2001) 1711-1718
4. Thompson P.L. Clinical relevance of statins: instituting treatment early in acute coronary syndrome patients. Atheroscler Suppl 2 (2001) 15-19
5. Newby L.K., Kristinsson A., Bhapkar M.V., et al. Early statin initiation and outcomes in patients with acute coronary syndromes. JAMA 287 (2002) 3087-3095
6. Mintz G.S., Nissen S.E., Anderson W.D., et al. American college of cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American college of cardiology task force on clinical expert consensus documents. J Am Coll Cardiol 37 (2001) 1478-1492
7. Kubo T., Imanishi T., Takarada S., et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol 50 (2007) 933-939
8. Kume T., Akasaka T., Kawamoto T., et al. Measurement of the thickness of the fibrous cap by optical coherence tomography. Am Heart J 152 755 (2006) e1-e4
9. Jang I.K., Tearney G.J., MacNeill B., et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 111 (2005) 1551-1555
10. Jang I.K., Bouma B.E., Kang D.H., et al. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol 39 (2002) 604-609
11. Yabushita H., Bouma B.E., Houser S.L., et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 106 (2002) 1640-1645
12. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis: characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 50 (1983) 127-134
13. Virmani R., Kolodgie F.D., Burke A.P., Farb A., and Schwartz S.M. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20 (2000) 1262-1275
14. Schwartz G.G., Olsson A.G., Ezekowitz M.D., et al. Myocardial ischemia reduction with aggressive cholesterol lowering (MIRACL) study investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285 (2001) 1711-1718
15. Cilingiroglu M., Oh J.H., Sugunan B., et al. Detection of vulnerable plaque in a mirine model of atherosclerosis with optical coherence tomography. Catheter Cardiovasc Interv 67 (2006) 915-923
16. Davies M.J., Richardson P.D., Woolf N., Katz D.R., and Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 69 (1993) 377-381
17. Shiomi M., Ito T., Tsukada T., et al. Reduction of serum cholesterol levels alter lesional composition of atherosclerotic plaques: effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits. Arterioscler Thromb Vasc Biol 15 (1995) 1938-1944
18. Guijarro C., Blanco-Colio L.M., Ortego M., et al. 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular sooth muscle cells in culture. Circ Res 83 (1998) 490-500
19. Takarada S., Imanishi T., Hano T., and Nishio I. Oxidized low-density lipoprotein sensitizes human vascular smooth muscle cells to FAS (CD95)-mediated apoptosis. Clin Exp Pharmacol Physiol 30 (2003) 289-294
20. Manfrini O., Mont E., Ornella L., et al. Sources of error and interpretation of plaque morphology by optical coherence tomography. Am J Cardiol 98 (2006) 156-159